fatty acid conjugate of selective estrogen receptor degrader (Novolipid)

N/A

Report date: 2025/01/26 18:10:54
NME

Base Information

Drug Namefatty acid conjugate of selective estrogen receptor degrader (Novolipid)
Drug Alias Namefatty acid conjugate of selective estrogen receptor degrader (University of North Carolina)NL4-PDG
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha degraders
TargetsEstrogen receptor alpha
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina, Greensboro
China Registration ClassN/A

Develop Information

Active CompaniesNovoLipid Inc
Inactive CompaniesUniversity Of North Carolina, Greensboro
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A